Kinnate Biopharma
KNTE
$2.65
Share price
0.00%
Change (1 day)
-22.06%
Change (1 year)
Categories
EPS for Kinnate Biopharma (KNTE)
EPS in 2023 (TTM): -$2.83
According to Kinnate Biopharma's latest financial reports the company's current EPS (TTM) is -$2.83. In 2022 the company made an earnings per share (EPS) of -$2.65 a decrease over its 2021 EPS that were of -$2.06.
EPS history for Kinnate Biopharma from 2020 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.83 | 6.79% |
| 2022 | -$2.65 | 28.64% |
| 2021 | -$2.06 | 92.98% |
| 2020 | -$1.07 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -22.97% | 🇺🇸 USA |